Recall Z-2703-2026— Siemens Healthcare Diagnostics, Inc.
Class II · Ongoing
Class II FDA medical device recall by Siemens Healthcare Diagnostics, Inc., initiated 2026-06-08. Product: Atellica CH Enzymatic Hemoglobin A1c (A1c_E). Material Number: 11097536.. Reason: The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results..
- Recalling firm
- Siemens Healthcare Diagnostics, Inc.
- Classification
- Class II
- Status
- Ongoing
- Initiated
- 2026-06-08
- Firm location
- Tarrytown, NY, United States
Product description
Atellica CH Enzymatic Hemoglobin A1c (A1c_E). Material Number: 11097536.
Reason for recall
The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results.
Data sourced from openFDA. This site is unofficial and independent of the FDA.